J.P. Morgan Private Wealth Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,247
| Closed | -$226K | – | 2054 |
|
|
2021
Q3 | $226K | Sell |
2,247
-21
| -0.9% | -$2.11K | ﹤0.01% | 1810 |
|
|
2021
Q2 | $321K | Sell |
2,268
-107
| -5% | -$15.1K | ﹤0.01% | 1651 |
|
|
2021
Q1 | $237K | Sell |
2,375
-43
| -2% | -$4.29K | ﹤0.01% | 1621 |
|
|
2020
Q4 | $299K | Sell |
2,418
-1,134
| -32% | -$140K | ﹤0.01% | 1499 |
|
|
2020
Q3 | $346K | Buy |
3,552
+618
| +21% | +$60.2K | ﹤0.01% | 1300 |
|
|
2020
Q2 | $458K | Buy |
2,934
+747
| +34% | +$117K | ﹤0.01% | 1141 |
|
|
2020
Q1 | $316K | Buy |
2,187
+338
| +18% | +$48.8K | ﹤0.01% | 1115 |
|
|
2019
Q4 | $378K | Buy |
+1,849
| New | +$378K | ﹤0.01% | 1145 |
|